Today's top stories in medicine:
Patients concerned about clinician burnout Burnout among health care providers was concerning to 74% of 2,007 survey respondents. Just over half said that they could tell when a provider was burned out, and 80% felt that the quality of their care was affected when their provider was burned out.
Food insecurity tied to migraine in young adults
Data were collected from a cross-sectional, nationally representative set of 14,786 young adults in the United States aged 24-32 years who participated in the 2008 National Longitudinal Study of Adolescent to Adult Health. In all, 1,647 study participants (11%) reported food insecurity; the prevalence of migraine in this group was 23.9%, compared with a prevalence of 13.6% in participants who did not report food insecurity.
Source: JAMA Neurology. 2019 June 24. doi: 10.1001/jamaneurol.2019.1663
Anticholinergic drugs linked to dementia in older populations
A large pharmacoepidemiologic study found an association between anticholinergic drug exposure and dementia risk in people aged 55 years or older. This was a nested case-control study of 58,769 patients with dementia and 225,574 matched controls. Prescription data related to 56 different drugs with strong anticholinergic properties, Exposure to antipsychotics (adjusted odds ratio, 1.70), bladder antimuscarinics (aOR, 1.65), antiepileptics (aOR, 1.39), antiparkinson agents (aOR, 1.52), and anticholinergic antidepressants (aOR, 1.29) was associated with an increased risk of dementia.
Source: JAMA Internal Medicine 2019 June 24, doi: 10.1001/jamainternmed.2019.0677
Imaging remission decried as ticket to RA overtreatment
The case for using ultrasound or MR to find inflammatory signatures in joints that can function as treatment targets collapsed earlier in 2019 with publication of results from IMAGINE-RA (An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis), a multicenter Danish study that randomized 200 RA patients in remission to either a conventional, disease activity-guided treatment target (in this case the DAS28-CRP [Disease Activity Score in 28 joints plus C-reactive protein]), or a treatment target that included the conventional clinical target plus treating to eliminate any bone marrow edema visualized by MRI. After 24 months of treatment, the prevalence of clinical remission and MRI remission was about the same in both arms, with no statistically significant differences. But serious adverse events in 6 patients managed by their clinical assessment compared favorably against 17 among those managed to an imaging remission endpoint, a difference that strongly hinted at dangerous overtreatment of the imaging-guided patients.
You can contact the MDedge Daily Medical News by emailing us at [email protected] or following us on Twitter at @MDedgeTweets